International Pharmaceutical Logistics & Delivery

The contract encompasses the international transportation and final delivery of pharmaceutical products from a U.S. supply point or origin to Liepāja, Latvia, under FOB Destination terms, meaning the responsibility and risk transfer to the recipient only upon arrival at the designated destination. This includes comprehensive logistics services such as customs clearance, appropriate packaging to meet pharmaceutical standards, and secure handling throughout the journey to ensure product integrity. The carrier must provide verified delivery confirmation upon completion, ensuring full traceability and compliance with regulatory requirements for sensitive medical goods. The work is classified under NAICS code 484220, indicating it falls under truck transportation of freight, and is structured as a subcontract under the Defense Logistics Agency, a branch of the Department of Defense. While specific performance locations and points of contact are not detailed, the contract is active under the procurement reference SPE2DP26F7562 and was posted on July 14, 2026, signaling a future operational window. All obligations are tied to the secure, timely, and compliant movement of pharmaceuticals across international borders, with an emphasis on meeting defense and healthcare logistics protocols.